Mara Aspinall president of Roche's Ventana
This article was originally published in Scrip
Ventana Medical Systems, part of the Roche group, has appointed Mara Aspinall president. Ms Aspinall was most recently the founder, president and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumour cell technology. She previously worked at Genzyme for 12 years in a number of senior leadership roles.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.